Skip to main content
OpenTrials
Completed

NCT Number: NCT04371198

Patient-Derived Organoids for Rectal Cancer

The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Duke Cancer Center

Durham, North Carolina, 27710, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion

  • Age ≥18 years old.
  • Able to provide informed consent.
  • Undergoing proctoscopy.

Exclusion

  • Patient not planned to receive neoadjuvant radiotherapy

Treatment and study plan

Biopsy

Other

Tissue biopsy

Primary outcomes

  1. Number of Participants With Biopsies That Form Spherical Organoids

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
May 1, 2020
Registry last updated
Aug 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.